Deep Signal: Skild AI Series C Funding Round
Skild AI closes $1.4B Series C led by SoftBank, reaching $14B valuation on foundation model robotics AI platform claiming omni-bodied control across heterogeneous robot morphologies.
- $1.4B Series C Funding Led by SoftBank, January 2026
- $14B Post-Money Valuation 3x increase from prior round
- $1.83B+ Total Capital Raised Largest single-round raise in robotics AI software history
- ~$30M 2025 Revenue Unaudited, claimed
- Founded
- Not disclosed in article
- Segments
- Humanoids·Autonomous Vehicles·Software
- Products
- Skild Brain
- Competitors
- Physical Intelligence·Field AI·1X Technologies·Flexion
Skild AI’s $1.4B Series C: The Foundation Model Bet Gets Expensive
What Happened
On January 14, 2026, Skild AI closed a $1.4 billion Series C led by SoftBank, pushing its valuation past $14 billion — a 3x increase from its prior round just seven months earlier. Total capital raised now exceeds $1.83 billion, making Skild AI the best-funded pure-play robotics AI software company globally by a significant margin. The investor syndicate reads like a strategic map of the company’s intended deployment verticals: Nvidia NVentures (hardware integration), Samsung and LG (consumer and industrial electronics), Schneider Electric (manufacturing and energy infrastructure), CommonSpirit Health (healthcare robotics), and Salesforce Ventures (enterprise software distribution).
The core product is Skild Brain, a unified foundation model claiming to control heterogeneous robot morphologies — quadrupeds, humanoids, tabletop arms, mobile manipulators — with minimal per-robot retraining. The company describes this as “omni-bodied” AI. Skild Brain is currently rated LIMITED deployment status, with approximately $30 million in claimed, unaudited 2025 revenue and no publicly named customers.
Why It Matters
The $14 billion valuation on ~$30 million in unaudited revenue represents a 467x revenue multiple. That number demands scrutiny. HIGH CONFIDENCE: this is the largest single-round raise in robotics AI software history. MODERATE CONFIDENCE: the valuation reflects strategic option value rather than current commercial performance.
The underlying technical thesis — that a single foundation model can generalize across robot morphologies without task-specific retraining — addresses a real and expensive problem. Per-robot, per-task training pipelines are a primary cost barrier to enterprise robotics adoption. If Skild Brain delivers on even a fraction of its generalization claims at production reliability, the total addressable market spans warehousing ($50B+ automation spend annually), manufacturing, healthcare, and critical infrastructure. The strategic investor composition suggests these verticals are not aspirational — they represent active go-to-market bets.
SoftBank’s participation is not incidental. The Vision Fund has deployed capital into humanoid robotics (Boston Dynamics, Figure AI) and is constructing a thesis around general-purpose robotic intelligence as the software layer above hardware. Skild AI fits that architecture precisely: hardware-agnostic, foundation-model-based, and positioned to capture margin at the intelligence layer rather than the commodity hardware layer. SoftBank is effectively betting that whoever owns the robotics OS wins disproportionate value as hardware costs commoditize.
The broader funding context reinforces the signal. Robotics startup funding reached $13.8 billion in 2025, up 77% from $7.8 billion in 2024. Capital is concentrating into foundation model approaches specifically, reflecting investor conviction that generalist control is the correct architectural direction.
Who Is Affected
The most directly affected competitor is Physical Intelligence (pi), which raised $400 million at a $2.4 billion valuation in late 2024 and is pursuing a similar foundation model approach for manipulation tasks. Skild AI now holds nearly 6x the capital and nearly 6x the valuation. Pi’s narrower focus on manipulation (versus Skild’s claimed full-morphology coverage) may prove a defensible niche, but the capital asymmetry creates real pressure on talent acquisition, data collection scale, and enterprise sales capacity.
Field AI, focused on autonomous inspection and infrastructure robotics, operates in one of Skild Brain’s stated target verticals. Field AI’s deployment-first approach — prioritizing fielded systems over broad generalization — represents a direct strategic contrast. If Skild Brain achieves reliable generalization, Field AI’s custom-trained models face margin compression. If Skild Brain fails to reach production reliability, Field AI’s approach is validated.
1X Technologies and Flexion, both pursuing generalist humanoid and manipulation control respectively, face similar dynamics: Skild AI’s capital base now enables a data acquisition and partnership strategy that smaller competitors cannot match on equivalent timelines.
Incumbent automation vendors — Zebra Technologies (whose robotics automation business Skild AI reportedly acquired, though this remains unverified), Teradyne/Universal Robots, and ABB Robotics — face a longer-term threat if Skild Brain’s orchestration layer gains adoption. The Symmetry Fulfillment platform, if confirmed as part of Skild’s portfolio, would provide an installed base and customer relationships that pure research-stage competitors lack entirely.
| Metric | Skild AI | Physical Intelligence | Field AI |
|---|---|---|---|
| Total Raised | >$1.83B | ~$400M | Undisclosed |
| Valuation | >$14B | ~$2.4B | Undisclosed |
| Deployment Status | LIMITED | LIMITED | FIELDED |
| Revenue (2025) | ~$30M (unaudited) | Not disclosed | Not disclosed |
| Morphology Scope | Multi (claimed) | Manipulation focus | Mobile platforms |
| Named Customers | None public | None public | Disclosed |
| Revenue Multiple | ~467x | N/A | N/A |
What to Watch
MODERATE CONFIDENCE that Skild AI announces at least one named enterprise customer with disclosed contract value before Q3 2026. The strategic investor syndicate creates natural pressure to convert relationships into reference deployments — Schneider Electric and CommonSpirit Health are the most likely first disclosures given their operational robotics needs.
HIGH CONFIDENCE that SoftBank pushes for a Skild Brain integration announcement with at least one humanoid hardware partner within 12 months, consistent with Vision Fund’s portfolio construction logic.
LOW CONFIDENCE that the Zebra Technologies robotics acquisition is formally confirmed or denied before mid-2026. The ambiguity here is a material information gap — the Symmetry Fulfillment platform would represent the most concrete commercial asset in Skild’s portfolio if confirmed.
Specific triggers to monitor:
- Q2 2026: Revenue verification — does Skild cross $50M ARR with auditable figures?
- Q3 2026: Named customer announcement with fleet size and uptime metrics
- Q4 2026: Skild Brain safety certification filing for any regulated vertical (healthcare, construction)
- 2026 full year: Whether Physical Intelligence raises a follow-on round that narrows the capital gap, or pivots toward acquisition discussions
The valuation velocity — $4.7B to $14B in seven months — is a signal worth flagging independently. MODERATE CONFIDENCE: this pace reflects genuine strategic competition for the foundation model category rather than pure speculative inflation. LOW CONFIDENCE: the $14B valuation is sustainable without $150M+ ARR within 24 months. The execution window is narrow, the capital is substantial, and the proof points remain almost entirely absent. That combination defines the next 18 months of Skild AI’s story.